Target intelligence / Profile preview

Novel transcript, sense intronic to CPVL (ENSG00000285081)

Target
ENSG00000285081
Molecular classification
Other (non-coding RNA), Intronic transcript
01

Overview

This gene, catalogued as ENSG00000285081, represents a novel non-coding transcript located within an intron of the CPVL gene. It is labelled "sense intronic to CPVL" meaning the transcript overlaps the CPVL gene in the sense orientation but is not protein-coding. There are no published studies or functional characterizations directly associating this transcript to a protein, receptor, therapeutic target, or disease biology. Its existence is based only on transcriptomic annotation and not on experimental evidence of function, protein expression, or target-related properties. The CPVL gene itself encodes a probable serine carboxypeptidase that may play a role in antigen processing, secretory pathways, and is implicated as a biomarker in some disease contexts. However, ENSG00000285081 refers to an intronic RNA, not the protein-coding CPVL gene. The "novel transcript" is a placeholder for a potentially uncharacterized or poorly understood non-coding RNA. There is no evidence for its utility as a drug target, biomarker, receptor, or mechanism for drug action. ENSG00000285081 is not a recognized therapeutic target, but rather a non-coding transcript without established function, mechanism, or pharmacological relevance. If you are seeking information on the CPVL enzyme itself, which is implicated in antigen processing and inflammation, refer to the gene symbol CPVL (Carboxypeptidase vitellogenic-like).

02

Biological functions

Unknown

Beyond the preview

Go deeper on Novel transcript, sense intronic to CPVL (ENSG00000285081).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, sense intronic to CPVL (ENSG00000285081).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call